HYDERABAD: Bharat Biotech International Limited (BBIL) and GSK plc on Wednesday announced a price reduction on the world’s ...

HYDERABAD: Vaccine maker Bharat Biotech International Ltd and British biopharma giant GSK plc will be slashing the prices of ...

Bharat Biotech has entered into partnership in 2021 to produce part of the malaria vaccine that has been developed by British ...

Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world’s first malaria ...

Hyderabad: Bharat Biotech will be reducing the price of world's first malaria vaccine RTS.S, developed by GSK, PATH and ...

GSK and Bharat Biotech collaborate to reduce malaria vaccine price, enhance production, and supply to Gavi by 2028.

Bharat Biotech International will start supplying world’s first malaria vaccine RTS.S, developed by global biopharma major GSK, to vaccine alliance Gavi from 2026.

Bharat Biotech and GSK will lower the malaria vaccine price to under $5 by 2028. This is due to better processes and more ...

LONDON (Reuters) -Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to $5 per dose by 2028, more ...

Bharat Biotech International Limited (BBIL) and GSK plc, a Global Pharma Company, today announced they will reduce the price of the world''s first malaria vaccine ''RTS,S'' for children developed by ...

Bharat Biotech and GSK to reduce RTS,S malaria vaccine price to under $5 per dose by 2028, enhancing access for children in ...

As part of a multi-year collaboration, GSK and India’s Bharat Biotech are redoubling their efforts to bring the world’s first malaria vaccine to more countries in need at affordable prices. | The ...